A Study to Evaluate the Safety and Efficacy of HB0052 in Patients With Advanced Solid Tumors

NCT06992687 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
ENROLLING_BY_INVITATION
Status
30
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Shanghai Huaota Biopharmaceutical Co., Ltd.

Collaborators